Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-30

Clinical Trial Update: Metronidazole SC Penetrance With Moisturizers [NA]

View source ↗

Summary

A completed clinical trial assessed metronidazole subcutaneous penetration with moisturizers in patients with rosacea (erythematotelangiectatic type).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Duke University | Conditions: Rosacea, Erythematotelangiectatic | NA | Status: COMPLETED